Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “EJACULATION”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 685 records · Page 38Linked to original sources

Apoptosis and kinematics of ejaculated spermatozoa in patients with varicocele.

Increased DNA fragmentation is found in sperm from infertile men. Varicocele is an important cause of male infertility, even though it is present in 15% of men who father children. Semen analysis does not always identify infertility in these patients. Sperm motility is strongly correlated with male fertility potential. The goal of this study was to determine the correlation between apoptosis and kinematics in the ejaculated spermatozoa of patients affected by varicocele. Fresh semen samples were obtained from 30 patients with varicocele and 15 fertile controls. These samples were compared using computer-assisted semen analysis and were assayed to determine the degree of sperm apoptosis. The apoptotic index (AI) was calculated by dividing the number of terminal deoxynucleotidyl transferase-mediated deoxyuridine-5'-triphosphate nick end labeling (TUNEL) stained spermatozoa by the total number of Hoechst 33258-stained sperm cells for 300 sperm. Five microscopic fields were analyzed to obtain 5 AIs for each individual. Results demonstrated no significant difference in semen quality and sperm motion characteristics; however, a significantly higher AI (23.05% +/- 4.07%: mean difference +/- SE, 95% CI, 15.06%-31.03%, P <.0001) was identified in the varicocele group than in the fertile controls. We concluded that sperm apoptosis does not seem to correlate with semen quality and sperm kinematics and that apoptosis is increased in ejaculated spermatozoa in patients with varicocele compared to normal fertile men.

Adult↗

Differential localization of glycoconjugates having affinity for concanavalin A on the surface of the sperm head in the testis, the epididymis, and the ejaculate of the ram.

The localization of Con A receptors on the surface of the head of ram spermatozoa originating from the rete testis, from three regions of the epididymis, or from the ejaculate was investigated using a gold-Con A labelling technique. Electron microscopic observation revealed three major localizations, each being characteristic of the origin of the spermatozoa: periacrosomal in the rete testis, postacrosomal in the epididymis, on the entire surface of the sperm head in the ejaculate.

Animals↗

Does in vitro capacitation alter chromatin stability of ejaculated human spermatozoa? Cytochemical studies.

In vitro capacitation of human spermatozoa is commonly evaluated by the progressive motility percent. However its effects on sperm chromatin have hardly been studied. Our aim was to determine the extent to which in vitro capacitation with two treatments (B2 or human follicular fluid) alters the chromatin of human spermatozoa, by using two analytical methods, acridine orange staining and Feulgen-DNA cytophotometric measures. Ejaculates were obtained from 23 men participating in our in vitro fertilization program, and several measurements were made on the same ejaculate for each subject. No alteration was observed for the percent of native DNA after capacitation in B2, but spermatozoa incubation during the same time in human follicular fluid was followed by a significant decrease of the percent of native DNA (P less than 0.01). Feulgen-DNA content significantly increased after capacitation in either B2 or follicular fluid (P less than 0.05, P less than 0.001 respectively), and so did sperm nuclear surface area (P less than 0.001). In this study we observed a negative correlation between Feulgen-DNA content and fertilization rate (P less than 0.02). Moreover, the greater effects on Feulgen-DNA content were observed in men with abnormal sperm, whose spontaneous percent of native DNA was lower (P less than 0.05) and Feulgen-DNA content higher (P less than 0.05) than in men with normal sperm. These results indicate that capacitation in B2 as well as in human follicular fluid may alter the chromatin stability of human spermatozoa. Such results suggest a partial decondensation state of human spermatozoa during in vitro capacitation. However, beyond some level of decondensation, the fertilizing ability could be altered.

Acridine Orange↗

Regulation of the bladder neck closure by lumbar splanchnic nerves at ejaculation in the dog.

To clarify the role of canine thoracolumbar splanchnic nerves for bladder neck closure during ejaculation, these nerves of adult male mongrel dogs were exposed under anesthesia using ketamine hydrochloride and pentobarbital, and electrical stimulation and anatomical dissection studies were performed. Bladder neck closure by the stimulation of each sympathetic nerve was monitored with a 10 Fr silicon catheter equipped with pressure-sensitive rubber balloon placed at the bladder neck. The dissection study revealed that canine thoracolumbar splanchnic nerves consisted of two nerve groups: one branching from the sympathetic trunks at thoracic and L1 ganglia, reaching caudal mesenteric plexus (CMP) through the anterior wall of the aorta, the other branching from the sympathetic trunks at level L2-L5 ganglia, reaching CMP through the posterior side of the bilateral spermatic arteries. The former were designated intermesenteric splanchnic nerves, the latter lumbar splanchnic nerves. No bladder neck closure was observed by electrical stimulation of the distal end of severed intermesenteric splanchnic nerves or of the sympathetic trunks at the lumbopelvic level among 10 dogs examined. At least one lumbar splanchnic nerve generated the closure in all 10 dogs and generally, a few lumbar splanchnic nerves, generated the closure. The results indicate that bladder neck closure during ejaculation is generated by lumbar splanchnic nerves regardless of their branching levels from lumbar sympathetic ganglia, but not by either intermesenteric splanchnic nerves or pelvic sympathetic trunks.

Animals↗

Case reports on the use of meditative relaxation as an intervention strategy with retarded ejaculation.

Two married males presented with psychogenic retarded ejaculation. Both reported the complete absence of ejaculation during sexual intercourse. Intervention consisted of meditative relaxation exercises together with supportive (brief) psychotherapy--for the husband and wife in both cases. Normal ejaculatory competence was reported by both subjects following 10-12 months of intervention. This was maintained at follow-up 14-16 months later.

Adult↗

Rapid ejaculation: a review of conceptual, etiological, and treatment issues.

A man's ability to control the timing of his ejaculation is a key aspect of his and his partner's sexual pleasure. This paper reviews the available clinical and experimental literature on rapid ejaculation (RE) highlighting methodological weaknesses common to research in the area. The numerous operational definitions of RE are reviewed. Inconsistencies among these definitions have led to difficulties in comparing studies. Empirical support for existing theories regarding the etiology of RE are reviewed. None has clear empirical support as being causally related to RE. The success of therapeutic interventions for RE are evaluated. The active ingredient(s) of therapeutic interventions for RE and the mechanisms by which they work have yet to be identified. Further, these treatments are far from universally successful, suggesting a need for additional approaches. A multivariate approach to operationalizing RE based on both ejaculatory latency and perceived control is proposed. This approach would also facilitate the understanding of both etiological and treatment issues.

Ejaculation↗

Sertraline in the treatment of premature ejaculation: a double-blind placebo controlled study.

This study investigated the efficacy and the adverse effects of sertraline in the treatment of premature ejaculation (PE). Thirty-seven patients with PE were randomly assigned to receive either sertraline or a placebo. Of them 22 were given 50 mg of sertraline per day and the other 15 patients were given an identical placebo one per day. After 4 weeks, the latency to ejaculation in the sertraline group was found to be significantly longer than that of the placebo group (p<0.01). None of the patients discontinued therapy due to adverse effects. These results indicate that sertraline is an effective therapy for PE.

Adult↗

Density and distribution of anionic sites on boar ejaculated and epididymal spermatozoa.

Current knowledge implies that spermatozoa successively acquire negative surface charges as they migrate through the epididymis. Until recently, however, techniques used were not amenable to statistical analysis. In the present study, a novel approach allowing numerical assessment of negative charge labelling was used in order to determine the density and distribution of anionic sites on ejaculated and maturing spermatozoa collected from six regions of the boar epididymis. Labelling was assessed quantitatively for the three morphologically distinct membrane domains on the sperm head. Statistical analysis revealed that labelling density was highest on efferent duct spermatozoa, declined up to the proximal corpus and then increased again. Densities of anionic sites on distal corpus, proximal cauda and ejaculated sperm cells were similar but significantly below the values obtained for efferent duct spermatozoa. All three sperm membrane domains underwent parallel changes. However, the overall density of negative charges on the postacrosomal segment was significantly higher as compared to the acrosomal plasma membrane. These alterations reflect sperm surface modifications through removal and addition of anionic groups. Since charge interactions are considered to play a pivotal role in sperm-egg interactions, these processes should be viewed as an integral part of sperm maturation.

Animals↗

Rapid ejaculation.

Rapid ejaculation, or premature ejaculatory dysfunction, is the most frequently encountered sexual complaint of men and couples. It is most common in adolescents, young adults, and other sexually naive males. Increased risk is associated with lack of sexual experience, lack of knowledge regarding normal male and female sexual responses, and with those individuals who highly associate psychological factors (such as fear, guilt, and anxiety) with sexual activity. This article provides a basic review of the pathophysiology of ejaculatory dysfunction and discusses the current treatment options for rapid ejaculation.

Animals↗

Treatment of premature ejaculation: new drugs and treatment strategies.

This review discusses treatment options for men with premature ejaculation (PE), a common sexual dysfunction characterized by short ejaculatory latency, decreased sexual satisfaction, and distress. For a number of reasons, including embarrassment and the belief that PE is a normal part of aging, has no effective treatment, or will resolve itself, few men with PE seek treatment. Although several treatment options exist (eg, behavioral, cognitive, and sex therapy methods; desensitizing drugs; off-label use of antidepressants and/or phosphodiesterase type 5 inhibitors or alpha-blockers), the majority of men with PE generally are not satisfied with their results. New pharmacologic drugs, specifically for the treatment of PE, are undergoing evaluation in clinical trials. As an example, recent clinical research studies have revealed on-demand administration of one such drug, dapoxetine, which achieved significant improvements in ejaculatory latency, control over ejaculation, and satisfaction with sexual intercourse. In addition, partners of men who received dapoxetine likewise reported improved satisfaction with sexual intercourse. Future studies may reveal that integration of pharmacologic drugs with psychologic and/or behavioral therapy techniques may be the optimal approach to the management of PE. PE is a treatable condition, and new drugs in development may provide benefits over those available.

Ejaculation↗

Metabolism of polyunsaturated fatty acids by an (n - 6)-lipoxygenase associated with human ejaculates.

Washed cells of normal human ejaculates were incubated with [14C]arachidonic acid (20:4(n - 6] at 37 degrees C for 30-40 min and the main product was characterized as 15(S)-hydroxy-5,8,11,13-eicosatetraenoic acid by reverse phase, straight phase and chiral phase high performance liquid chromatography (HPLC) and by capillary gas chromatography-mass spectrometry. The biosynthesis of 15(S)-hydroxy-5,8,11,13-eicosatetraenoic acid from exogenous 20:4(n - 6) was inhibited by nordihydroguaiaretic acid and abolished by heat inactivation, but it appeared to be unaffected by the ionophore A23187 and Ca2+. Human spermatozoa were partly purified from contaminating material by the swim-up procedure and incubated with 14C-labelled 18:2(n - 6), 20:4(n - 6), 22:5(n - 6) and 22:6(n - 3) for 30-40 min at 37 degrees C. The main radiolabelled products, which were obtained in low yields, co-chromatographed with the Ls (n - 6)-hydroxy fatty acid of each substrate on reverse phase, straight phase and chiral phase HPLC. The (n - 6)-lipoxygenase was also present in ejaculates with oligozoospermia or azoospermia. The seminal fluid contains membrane-surrounded organelles (e.g., 'prostasomes' secreted by the prostate gland) and the (n - 6)-lipoxygenase was present and appeared to be relatively prominent in almost cell-free preparations of organelles of seminal fluid. The (n - 6)-lipoxygenase activity associated with the spermatozoa may thus be explained by the presence of prostasomes or other organelles, which may conceivably bind to the spermatozoon through hydrophobic interactions.

Arachidonic Acids↗

A clinical trial of the beta blocker propranolol in premature ejaculation.

Twelve male patients, with a primary complaint of premature ejaculation in a setting of chronic anxiety with prominent somatic manifestations, participated in a double-blind trial: propranolol against placebo. The study consisted of 5 X 4 week phases: run-in, propranolol or placebo--120 mg/day allocated randomly, wash-out; placebo or propranolol and run-out, in a balanced design. Anxiety was rated initially, and every 2 weeks, throughout the trial using the Hamilton Rating Scale. Sitting blood pressure and pulse were also noted. The time to coital ejaculation (every 3 days) was recorded using a stopwatch, and subjects were also required to rate "overall coital satisfaction" and "quality of erection". Neither prematurity nor other signs/symptoms of anxiety improved on the preparations, which were statistically equivalent. Moderate beta-blockade was achieved with propranolol as evidenced by a median reduction in pulse rate of 5 beats/min.

Adolescent↗

Successful artificial insemination in a case of retrograde ejaculation.

A case is described of retrograde ejaculation due to bladder neck resection followed by ileal conduit with a non-functioning bladder, where, after unsuccessful attempts at artificial insemination with spermatozoa retrieved from the bladder, ejaculate was obtained at defecation followed by artificial autoinsemination by the male, leading to two consecutive pregnancies.

Adult↗

Further evaluation of the split ejaculate for artificial insemination.

The role of artificial insemination with husband semen (AIH) in solving fertility problems has been studied by many investigators. Different conclusions have been made due to the variety of indications for AIH. This communication attempts to evaluate the use of the best split ejaculate fraction for AIH in 55 couples in which the only pathological condition was oligozoospermia or oligoasthenozoospermia. Couples in which the women had a known history of anatomical abnormalities were excluded. Although the seminal parameters of spermatozoal density and/or motility in the best split fractions were frequently found to be in the fertile range, the pregnancy rate achieved was only 18% (n = 10). This was comparable to the results obtained by others using whole ejaculates for AIH. The spontaneous pregnancy rate in the present study after termination of treatment was 13% (n = 6). The observations suggest that men with a long-standing history of seminal deficiency produce spermatozoa with a pathology that cannot be microscopically recognized.

Adult↗

Retrograde ejaculation: a more convenient method for artificial insemination.

A case of retrograde ejaculation not responding to medical treatment is described in which the problem of sterility was overcome by artificial insemination. The semen was collected from urine after coitus by previous alkalinization with 1.63 g NaHCO3 once daily. Pregnancy occurred at the 4th insemination during the 1st treatment cycle. This technique seems to be the most suitable for artificial insemination in cases of retrograde ejaculation.

Adult↗

Ejaculations induced by p-chloroamphetamine in the rat.

The ejaculatory response following acute injections of p-chloroamphetamine (PCA) and several other drugs was measured by weighing the compact seminal material accumulated over 2 hr. p-Chloroamphetamine caused a dose-dependent ejaculatory response that was inhibited by the inhibitor of the synthesis of 5-hydroxytryptamine (5-HT), p-chlorophenylalanine (PCPA), neurotoxic doses of PCA, reserpine, DSP 4 a selective noradrenergic neurotoxin given 48 hr before PCA, the inhibitor of synthesis of noradrenaline (NA) FLA 63, the specific inhibitors of uptake of 5-HT, alaproclate, fluoxetine and norzimeldine and the selective inhibitor of the uptake of NA, CPP 199, the E form of norzimeldine. The doses of several receptor antagonists producing a 50% decrease in the weight of seminal material were determined. The non-selective 5-HT receptor antagonists, metitepine and methergoline, the selective alpha 1-adrenoreceptor antagonists, prazosin and phenoxybenzamine and the non-selective alpha-adrenoreceptor antagonist, phentolamine, had strong effects, followed by the selective 5-HT2 antagonists, ketanserin and pirenperone. Yohimbine, an alpha 2-adrenoreceptor antagonist and atropine, a muscarinic receptor antagonist, only produced a partial blockade. The rank order of potency for some dopamine (DA) receptor antagonists was chlorpromazine, domperidone, haloperidol, pimozide. Remoxipride, a selective DA2 receptor antagonist and the selective DA1 antagonist, Sch 23390, had no effect. The following drugs had no effect: propranolol, naloxone, picrotoxin, cimetidine and mepyramine. The 5-HT receptor agonist 5-methoxy-N,N-dimethyltryptamine (5-MeODMT 3 mg/kg, i.p.) produced a small effect on the weight of seminal material, although 72% of the rats ejaculated. d-Amphetamine did not induce ejaculation at 5 mg/kg but had a marked effect at 15 mg/kg.(ABSTRACT TRUNCATED AT 250 WORDS)

Amphetamines↗

Rectal ejaculation and prostatic carcinoma.

A case of carcinoma of the prostate causing fistulous communication between the rectum and the prostatic ducts is presented. The patient's initial symptoms included gradual onset of inability to ejaculate and the complaint of ejaculation per rectum. Appropriate urologic studies demonstrated a fistulous connection between the area of the ejaculatory duct and the rectum. Microscopic studies of rectal discharge confirmed that semen was exiting through his rectum. All genitourinary symptoms in patients with carcinoma of the prostate warrant thorough investigation.

Adenocarcinoma↗

Failure of naloxone to block the reduction in burying behaviour after ejaculation in male rats.

In the present study we analyzed whether the opiate nociceptive system participates in the reduction in burying behaviour observed after ejaculation. To that purpose the opiate antagonist naloxone (0.5, 1.0 and 2.0 mg/kg) was administered before ejaculation. The results showing that this antagonist does not interfere with the drastic reduction in burying behaviour suggest that an opiate nociceptive mechanism is not involved in this effect. Present data further support the idea that the reduction in burying behaviour is reflecting a specific reduction in anxiety.

Animals↗